This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience Companies East
Delivered as a Hybrid Event
September 19-20, 2022Boston, MA

Jeffrey Baumel
Partner at Dentons


Jeffrey Baumel heads the US securities practice and co-leads the Firm's Life Sciences and Health Care industry sector, representing a broad range of companies in the life sciences, biotechnology and technology industries. His deep securities law experience comes from working with issuers, underwriters and venture capital investors on a wide range of transactions. These have included public offerings and private placements of equity and debt securities involving hundreds of millions of US dollars. In addition, Jeffrey has worked extensively with venture capital and investment banking firms specializing in growth-stage ventures.

Jeffrey advises boards of directors on complex corporate governance and compliance matters. He also represents both public and private companies in connection with corporate and commercial transactions, including mergers and acquisitions. A chair of the BioNJ Venture Capital Forum, Jeffrey also speaks regularly on issues relating to finance, corporate governance and securities law.

Jeffrey Baumel's Network

Agenda Sessions

  • Biotech Equity Funding Models and Pathways — Venture Capital and the Public Markets